Physician Assistant Program year 2023 Reported 2022–2023 Source: CMS Open Payments, 2026 publication

Aubrey Barton

Physician Assistant Missoula, MT Physician Assistant

NPI 1578914479 CMS profile 10513118

2360 Mullan Rd Ste C, Missoula, MT 59808

Open in the dashboard

General payments

$231

2 records reported · program years 2022–2023

Research payments

$0

Paid to them · None reported · program years 2022–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Aubrey Barton of Missoula, MT is reported in the CMS Open Payments database as having received $231 across 2 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 41st percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $115 1
2022 General $116 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Aubrey Barton
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Aubrey Barton were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Aubrey Barton Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $116 $155 $48–$522 $149
2023 $115 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2022–2023
  1. DePuy Synthes Sales Inc. $116 1 payment
  2. Stryker Corporation $115 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2023
  1. Food and Beverage $231 2 payments
Products named General payments · program years 2022–2023
  1. MAKO $115 1 payment
  2. HOFFMANN $115 1 payment
  3. TRIATHLON $115 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

532

Median for Physician Assistant: 241

Drug cost

$4,675

Median for Physician Assistant: $4,110

Branded share of claims

16%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 33 $1,497
Ondansetron Odt Ondansetron Brand 73 $945
Oxycodone Hcl Generic 98 $551
Gabapentin Generic 71 $459
Methocarbamol Generic 64 $278
Cefadroxil Generic 35 $212
Meloxicam Generic 60 $181
Hydromorphone Hcl Generic 19 $138
Doxycycline Hyclate Generic 18 $137
Methylprednisolone Generic 27 $132

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$34,382

Of which drugs: $363

Medicare patients

284

Average age 73

Services billed

3,824

174 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 69%
High blood pressure 63%
Ischemic heart disease 21%
Depression 21%
Osteoporosis 16%
Atrial fibrillation 15%
Chronic kidney disease 15%
Diabetes 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 34 3,240 $315

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

2 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Montana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record